ORBIMED ADVISORS LLC – Theravance Biopharma, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$0
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+11.92%
quarter
Theravance Biopharma, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -100.00% | -1.37M shares | -12.41M | $10.14 | 0 |
Q2 2022 | share | Decrease | -57.90% | -1.88M shares | -18.70M | $9.06 | 1.37M |
Q1 2022 | share | Decrease | -45.52% | -2.71M shares | -34.90M | $9.56 | 3.25M |
Q4 2021 | share | Increase | +1.35% | 79.37K shares | 22.39M | $10.98 | 5.97M |
Q3 2021 | share | Increase | +29.17% | 1.33M shares | -22.64M | $7.4 | 5.89M |
Q2 2021 | share | Decrease | -26.61% | -1.65M shares | -60.66M | $14.52 | 4.56M |
Q1 2021 | share | 0.00% | 0 shares | 16.41M | $20.41 | 6.21M | |
Q4 2020 | share | 0.00% | 0 shares | 18.56M | $17.77 | 6.21M | |
Q3 2020 | share | Increase | +143.46% | 3.66M shares | 38.33M | $14.79 | 6.21M |
Q2 2020 | share | Increase | +1107.53% | 2.34M shares | 48.72M | $20.99 | 2.55M |
Q1 2020 | share | Increase | 0.00% | 211.54K shares | 4.88M | $23.11 | 211.54K |